Clinical trial · Observational
Comparison of Two Preparations for the Study of the Colon Through Colonoscopy
Comparative, Prospective and Randomized Study of Two Preparations for the Study of the Colon Through Colonoscopy
NCT04497935CI-TRIAL-00046412completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Compare the quality of bowel preparation between two groups of patients, who will undergo two different preparations: 1. Moviprep + diet; 2. Plenvu + diet
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Colon Adenoma | Colon Adenoma | ONTOLOGY_EXACT | 0.98 |
| Colon Cancer | Malignant Colon Neoplasm | CURATED_EXACT | 0.92 |
| Colon Polyp | — | UNRESOLVED | — |
| Colon Rectal Cancer | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| MoviPrep | Drug | — | UNRESOLVED |
| PLENVU | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- 1LPEG
- description
- Patients receiving 1LPEG who had a colonoscopy in the morning were advised to follow a day-before dosing regimen, where, at 7:00 pm the day before the colonoscopy, they prepared the Dose 1 sachet in 500 mL of water and consumed it over a period of 30 minutes, followed by 500 mL of clear liquids. The second dose was then taken at 11:00 pm by mixing the two Dose 2 sachets in a single glass of 500 mL of water and consuming them over 30 minutes, followed by 500 mL of clear liquids. If the colonoscopy was scheduled for the afternoon, the same dosing instructions were given, but the first dose was taken at 7:00 am on the day of the procedure, and the second dose began at 10:00 am.
- interventionNames
- Drug: PLENVU
- label
- 2LPEG
- description
- Patients receiving 2LPEG who had a colonoscopy in the morning were asked to follow a similar day-before dosing regimen, where, at 7:00 pm the day before the colonoscopy, the first 1L dose was consumed over a 1-hour period, followed by the second dose at 11:00 pm. For 2LPEG patients with procedures in the afternoon, they took Dose 1 at 7:00 am and Dose 2 at 10:00 am. Any patient receiving 2LPEG was also told to consume 1L of clear liquids during the preparation procedure.
- interventionNames
- Drug: MoviPrep
Primary outcomes (1)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * All patients aged \> 18 years and indicated for examination requiring bowel preparation Exclusion Criteria: * Pregnant or breastfeeding women * Patients with gastroparesis or gastric obstruction. * Patients with psychiatric disorders * Severe renal impairment with CrCl \<30mL/min * Class III-IV Heart Failure * Dependence / use of laxatives * Chronic constipation (\<3 stools/week). * Uncontrolled hypertension (SBP \>170mmHg or DBP \>100mmHg) * Intestinal Obstruction * Colostomy from previous intestinal surgery * Severe ascites * Refusal of participation in the study * Patients unable to understand or respond to the satisfaction survey
References
Publications (0)
Data not yet available
No reference posted for this study.